Detalles de la búsqueda
1.
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Lancet Oncol
; 22(12): 1777-1786, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780711
2.
Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA.
Lancet Haematol
; 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797190
3.
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases.
Radiat Oncol
; 16(1): 31, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33557890
4.
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and -γ.
Front Immunol
; 12: 718621, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34512641
5.
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
Int J Radiat Oncol Biol Phys
; 109(4): 867-879, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340603
6.
Whole-lung low-dose radiation therapy (LD-RT) for non-intubated oxygen-dependent patients with COVID-19-related pneumonia receiving dexamethasone and/or remdesevir.
Radiother Oncol
; 165: 20-31, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34653525
Resultados
1 -
6
de 6
1
Próxima >
>>